News

  • Dr Kate Lawlor's research at Hudson Institute aims at taming inflammation.

    Finding the triggers of inflammation

    Chronic or acute inflammation can contribute to a range of ailments – some potentially deadly – including stroke, respiratory and heart disease, cancer, arthritis, asthma, dementia, multiple sclerosis, and diabetes.…  Read more

  • Professor Suzanne Miller Heads up The Ritchie Centre at Hudson Institute of Medical Research

    New Head for The Ritchie Centre

    Professor Suzanne Miller, scientific leader in fetal and neonatal neurodevelopment, has been appointed as the new Head of The Ritchie Centre.…  Read more

  • Dr Minna-Liisa Änkö discovers the key to platelet production and understanding RNA.

    RNA platelet discovery could ease load on blood donors

    A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets.…  Read more

  • Professor Brendan Jenkins uncovers a stomach cancer trigger, providing vital clues to the origins of the world’s third-most-common cancer.

    Stomach cancer trigger revealed

    Researchers in Melbourne have uncovered a stomach cancer trigger, providing vital clues to the origins of the world’s third-most-common cancer.…  Read more

  • Scientist in the Neurodevelopment and Neuroprotection Research Group at Hudson Institute research further into preventing brain injury in babies.

    Preventing brain injury in babies

    It’s always been accepted that the time of birth is a period of high risk, but new research shows that the developmental period in utero can be problematic for some babies, particularly those with low birth weight.…  Read more

  • Associate Professor Michael Gantier's groundbreaking research into inflammation has attracted funding support from the Victorian government to assist with new anti-inflammatory treatments.

    Victorian government funding boost for new anti-inflammatory treatments

    Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

  • Associate Professor Robin Hobbs uncovers a vital pathway to restoring men's fertility after cancer.

    Restoring men’s fertility after cancer

    A tragic side-effect of chemotherapy might soon be a thing of the past, with researchers uncovering a vital pathway to restoring men’s fertility after cancer.…  Read more

  • Eight-year-old Neve presents fundraising cheque to riders finishing Ride4Research.

    COVID can’t stop cancer pioneer finishing his Ride4Research

    Not even Covid-19 could stop a pioneer in the fight against rare ovarian cancers finishing his epic fundraising ride. In early May Dr Simon Chu took a break from the lab and put rubber on the road in the Ride4Research, aiming to cover 900km in 9 days from Canberra to Melbourne.…  Read more

  • Professor Rob McLachlan, Dr Sarah Catford from Hudson Institute discover that fertility unaffected in men born from ICSI.

    Concerns eased over ICSI male infertility

    Fertility concerns have eased among the children of IVF/intracytoplasmic sperm injection (ICSI), with new research showing little or no difference in male fertility levels among men born from ICSI.…  Read more

  • Associate Professor Michael Gantier has been awarded a new grant to research further into RNA-based treatments for autoimmune diseases.

    RNA boost for autoimmune disease

    The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected